Literature DB >> 23675665

Rivaroxaban for thromboprophylaxis in acutely ill medical patients.

Alexander T Cohen, Theodore E Spiro, Alex C Spyropoulos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23675665     DOI： 10.1056/NEJMc1303641

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment.

Authors:  J C Easaw; M A Shea-Budgell; C M J Wu; P M Czaykowski; J Kassis; B Kuehl; H J Lim; M MacNeil; D Martinusen; P A McFarlane; E Meek; O Moodley; S Shivakumar; V Tagalakis; S Welch; P Kavan
Journal:  Curr Oncol       Date:  2015-04       Impact factor: 3.677

2.  Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxis.

Authors:  J C Easaw; M A Shea-Budgell; C M J Wu; P M Czaykowski; J Kassis; B Kuehl; H J Lim; M MacNeil; D Martinusen; P A McFarlane; E Meek; O Moodley; S Shivakumar; V Tagalakis; S Welch; P Kavan
Journal:  Curr Oncol       Date:  2015-04       Impact factor: 3.677

3.  Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer.

Authors:  Cecilia Becattini; Fabio Rondelli; Maria C Vedovati; Giuseppe Camporese; Michela Giustozzi; Michela Boncompagni; Salvatore Pucciarelli; Ruben Balzarotti; Enrico Mariani; Esmeralda Filippucci; Annibale Donini; Giancarlo Agnelli
Journal:  Haematologica       Date:  2014-09-12       Impact factor: 9.941

4.  Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial.

Authors:  Jeffrey I Zwicker; Joanna Roopkumar; Maneka Puligandla; Benjamin L Schlechter; Anish V Sharda; David Peereboom; Robin Joyce; Bruno Bockorny; Donna Neuberg; Kenneth A Bauer; Alok A Khorana
Journal:  Blood Adv       Date:  2020-05-26

Review 5.  Primary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers - Review.

Authors:  Hanno Riess; Piet Habbel; Anja Jühling; Marianne Sinn; Uwe Pelzer
Journal:  World J Gastrointest Oncol       Date:  2016-03-15

6.  Rivaroxaban improves patency and decreases inflammation in a mouse model of catheter thrombosis.

Authors:  Christi M Terry; Yuxia He; Alfred K Cheung
Journal:  Thromb Res       Date:  2016-06-09       Impact factor: 3.944

7.  Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: A trial sequential and cumulative meta-analysis.

Authors:  Navkaranbir S Bajaj; Muthiah Vaduganathan; Arman Qamar; Kartik Gupta; Ankur Gupta; Harsh Golwala; Javed Butler; Samuel Z Goldhaber; Mandeep R Mehra
Journal:  PLoS Med       Date:  2019-04-29       Impact factor: 11.069

Review 8.  Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants.

Authors:  Waqas Qureshi; Zeeshan Ali; Waseem Amjad; Zaid Alirhayim; Hina Farooq; Shayan Qadir; Fatima Khalid; Mouaz H Al-Mallah
Journal:  Front Cardiovasc Med       Date:  2016-07-28

9.  Postdischarge thrombosis and hemorrhage in patients with COVID-19.

Authors:  Rushad Patell; Thomas Bogue; Anita Koshy; Poorva Bindal; Mwanasha Merrill; William C Aird; Kenneth A Bauer; Jeffrey I Zwicker
Journal:  Blood       Date:  2020-09-10       Impact factor: 22.113
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.